Objective: To identify factors influencing pharmacists' decisions about selling syringes to injection drug users (IDUs).
Design: Audiotaped interviews.
Setting: Denver, Colorado.
Participants: Thirty-two pharmacists at 24 pharmacies.
Intervention: One-hour semistructured interviews.
Main Outcome Measures: Practices regarding syringe sales to IDUs and factors influencing the practices.
Results: Of the 32 pharmacists interviewed, 16 indicated that they sold syringes to all customers ("pro-sell"), 11 refused to sell unless shown proof of diabetic status ("no-sell"), and 5 were "undecided." Several factors influenced the decision to sell. A perceived conflict between prevention of disease and prevention of drug abuse most clearly distinguished the three categories, with pro-sell pharmacists more likely than others to prioritize disease prevention and believe that syringe sales would not increase drug abuse. Business concerns, such as the effect of the presence of IDUs on other customers and the possibility of discarded syringes around the store, were especially prevalent among no-sell and undecided pharmacists. Seventeen pharmacists did not know about Colorado laws governing syringe sales. Four no-sell pharmacists used the laws to justify their decision not to sell, and two undecided pharmacists said they used the law when they did not want to sell syringes to IDU. All pharmacists supported syringe exchange programs.
Conclusion: One-half of the pharmacists sold syringes to IDUs, and several more indicated that they would do so if certain concerns were addressed. These data suggest that improved syringe disposal options, continuing education programs, and clarification of existing laws and regulations would encourage more pharmacists in Denver to sell syringes to IDUs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1331/1086-5802.42.0.s46.lewis | DOI Listing |
J Am Pharm Assoc (2003)
November 2024
UNC Eshelman School of Pharmacy, 201 Pharmacy Lane, CB 7355, Chapel Hill, NC, 27599-7355, USA.
Background: There's limited information available about the range of harm reduction (HR) services provided by rural pharmacies.
Objective: This study's objectives are to describe the types of HR services offered by rural pharmacies and examine pharmacists' attitudes and willingness to offer those services.
Methods: A cross-sectional online survey was sent to pharmacists who are members of a practice-based research network for rural community pharmacies.
Res Social Adm Pharm
August 2024
Harm Reduction Research Lab, Department of Family and Community Medicine, College of Medicine-Tucson, Tucson, University of Arizona, USA; Department of Health Education and Promotion, College of Health and Human Performance, East Carolina University, Greenville, NC, USA.
Background: Pharmacy syringe sales are effective structural interventions to reduce bloodborne illnesses in populations, and are legal in all but two states. Yet evidence indicates reduced syringe sales in recent years. This study was designed as a feasibility test of an intervention to promote syringe sales by pharmacies in Arizona.
View Article and Find Full Text PDFTrop Anim Health Prod
May 2024
Center of Veterinary Parasitology, School of Veterinary Science and Animal Science, Federal University of Goiás, Goiânia, Goiás, Brazil.
This study aimed to investigate seven outbreaks of A. marginale infection in two regions of Brazil, affecting taurine, zebu, and crossbred cattle. We assessed the possible causes, treatment measures, and genetic diversity of A.
View Article and Find Full Text PDFCochrane Database Syst Rev
March 2024
Ophthalmology, St Thomas' Hospital, London, UK.
Background: A macula-involving rhegmatogenous retinal detachment (RRD) is one of the most common ophthalmic surgical emergencies and causes significant visual morbidity. Pars plana vitrectomy (PPV) with gas tamponade is often performed to repair primary macula-involving RRDs with a high rate of anatomical retinal reattachment. It has been advocated by some ophthalmologists that face-down positioning after PPV and gas tamponade helps reduce postoperative retinal displacement.
View Article and Find Full Text PDFRes Social Adm Pharm
May 2024
Opioid Policy Research Collaborative, Heller School for Social Policy & Management at Brandeis University, Waltham, MA, USA; Departments of Emergency Medicine and Epidemiology, Brown Schools of Medicine and Public Health, Providence, RI, USA. Electronic address:
Background: Community pharmacies are well-positioned to improve the health of people with opioid use disorder and who use drugs by providing naloxone and other essential public health supplies. Respond to Prevent (R2P) is a clinical trial which sought to accelerate provision of harm reduction materials through a multicomponent intervention that included in-store materials, online training, and academic detailing.
Objectives: The objective of this study was to explore pharmacists' attitudes, knowledge, and experiences in providing naloxone, dispensing buprenorphine, and selling nonprescription syringes following participation in the R2P program.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!